Matinas BioPharma Holdings, Inc. SEC filings MTNB

Matinas BioPharma Holdings, Inc. has 570 filings in SEC EDGAR's recent list, going back to Jul 25, 2013. Its latest annual report, Form 10-K, was filed on Mar 31, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 13, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Nov 3, 2026 (other events). The company's fiscal year ends on December 31.

Matinas BioPharma Holdings, Inc. SEC filings
Form Description Filed Period
8-K Current report
Other events
Nov 3, 2026 Nov 3, 2026
8-K Current report
Change to shareholder rights, Bylaw or fiscal year change
Sep 28, 2026 Sep 25, 2026
8-K Current report
Other events
Sep 16, 2026 Sep 16, 2026
8-K Current report
Listing notice, Other events
Sep 4, 2026 Aug 31, 2026
425 Filing Aug 25, 2026 —
10-Q Quarterly report Aug 13, 2026 Jun 30, 2026
425 Filing Aug 4, 2026 —
425 Filing Jul 30, 2026 —
425 Filing Jul 29, 2026 —
8-K Current report
Agreement ended
Jul 24, 2026 Jul 23, 2026
425 Filing Jul 21, 2026 —
425 Filing Jul 16, 2026 —
425 Filing Jul 13, 2026 —
8-K Current report
Material agreement, Unregistered share sale, Change to shareholder rights, Change in control, Officer or director change, Bylaw or fiscal year change, Regulation FD disclosure, Other events
Jul 13, 2026 Jul 10, 2026
8-K Current report
Listing notice, Other events
Jun 26, 2026 Jun 24, 2026
424B7 Filing Jun 22, 2026 —
S-3 Shelf registration Jun 16, 2026 —
10-Q Quarterly report May 8, 2026 Mar 31, 2026
8-K Current report
Listing notice
Apr 3, 2026 Apr 2, 2026
10-K Annual report Mar 31, 2026 Dec 31, 2025
8-K Current report
Officer or director change
Jan 23, 2026 Jan 22, 2026
8-K Current report
Officer or director change
Dec 12, 2025 Dec 12, 2025
8-K Current report
Officer or director change
Nov 21, 2025 Nov 18, 2025
10-Q Quarterly report Nov 10, 2025 Sep 30, 2025
8-K Current report
Material agreement, Unregistered share sale
Aug 18, 2025 Aug 15, 2025
10-Q Quarterly report Aug 14, 2025 Jun 30, 2025
8-K Current report
Bylaw or fiscal year change
Aug 6, 2025 Aug 6, 2025
S-8 Employee stock plan registration Jun 23, 2025 —
8-K Current report
Officer or director change, Shareholder vote results
Jun 23, 2025 Jun 23, 2025
10-Q Quarterly report May 15, 2025 Mar 31, 2025
DEF 14A Proxy statement May 12, 2025 May 12, 2025
PRE 14A Preliminary proxy statement May 2, 2025 May 2, 2025
8-K Current report
Change to shareholder rights, Officer or director change, Other events
May 2, 2025 Apr 30, 2025
EFFECT Filing Apr 29, 2025 —
ARS Annual report to shareholders Apr 29, 2025 Dec 31, 2024
424B3 Prospectus Apr 29, 2025 —
CORRESP Letter to the SEC Apr 28, 2025 —
UPLOAD Letter from the SEC Apr 28, 2025 —
S-3 Shelf registration Apr 22, 2025 —
10-K Annual report Apr 15, 2025 Dec 31, 2024
8-K Current report
Unregistered share sale, Other events
Apr 8, 2025 Apr 8, 2025
8-K Current report
Shareholder vote results
Apr 4, 2025 Apr 4, 2025
NT 10-K Filing Mar 31, 2025 Dec 31, 2024
8-K Current report
Officer or director change
Mar 14, 2025 Mar 13, 2025
8-K Current report
Officer or director change, Other events
Mar 11, 2025 Mar 11, 2025
DEF 14A Proxy statement Mar 3, 2025 Mar 3, 2025
PRE 14A Preliminary proxy statement Feb 21, 2025 Feb 21, 2025
D Filing Feb 19, 2025 —
8-K Current report
Material agreement, Unregistered share sale, Change to shareholder rights, Officer or director change, Bylaw or fiscal year change, Other events
Feb 13, 2025 Feb 13, 2025
8-K Current report
Officer or director change
Feb 11, 2025 Feb 5, 2025
8-K Current report
Officer or director change, Other events
Feb 7, 2025 Feb 5, 2025
8-K Current report
Officer or director change
Jan 24, 2025 Jan 21, 2025
8-K Current report
Listing notice
Jan 10, 2025 Jan 6, 2025
8-K Current report
Officer or director change
Nov 27, 2024 Nov 27, 2024
10-Q Quarterly report Nov 13, 2024 Sep 30, 2024
8-K Current report
Exit or restructuring costs, Impairment, Officer or director change, Regulation FD disclosure, Other events
Oct 31, 2024 Oct 31, 2024
8-K Current report
Officer or director change
Oct 24, 2024 Oct 23, 2024
8-K Current report
Change to shareholder rights, Bylaw or fiscal year change
Sep 3, 2024 Aug 30, 2024
8-K Current report
Other events
Aug 28, 2024 Aug 27, 2024
8-K Current report
Other events
Aug 20, 2024 Aug 20, 2024
8-K Current report
Results of operations, Regulation FD disclosure
Aug 14, 2024 Aug 14, 2024
10-Q Quarterly report Aug 14, 2024 Jun 30, 2024
8-K Current report
Results of operations
May 9, 2024 May 9, 2024
10-Q Quarterly report May 9, 2024 Mar 31, 2024
8-K Current report
Material agreement, Regulation FD disclosure
Apr 5, 2024 Apr 2, 2024
424B5 Prospectus supplement Apr 4, 2024 —
8-K Current report
Regulation FD disclosure
Mar 28, 2024 Mar 28, 2024
8-K Current report
Results of operations
Mar 27, 2024 Mar 27, 2024
10-K Annual report Mar 27, 2024 Dec 31, 2023
8-K Current report
Regulation FD disclosure, Other events
Mar 25, 2024 Mar 25, 2024
8-K Current report
Regulation FD disclosure, Other events
Mar 22, 2024 Mar 22, 2024
8-K Current report
Other events
Mar 22, 2024 Mar 22, 2024
8-K Current report
Regulation FD disclosure, Other events
Feb 26, 2024 Feb 26, 2024
8-K Current report
Regulation FD disclosure, Other events
Feb 20, 2024 Feb 20, 2024
8-K Current report
Regulation FD disclosure
Jan 9, 2024 Jan 9, 2024
8-K Current report
Regulation FD disclosure, Other events
Dec 27, 2023 Dec 27, 2023
8-K Current report
Regulation FD disclosure, Other events
Dec 21, 2023 Dec 21, 2023
8-K Current report
Regulation FD disclosure
Nov 20, 2023 Nov 20, 2023
8-K Current report
Regulation FD disclosure, Other events
Nov 9, 2023 Nov 7, 2023
8-K Current report
Results of operations
Nov 8, 2023 Nov 8, 2023
10-Q Quarterly report Nov 8, 2023 Sep 30, 2023
8-K Current report
Shareholder vote results
Nov 2, 2023 Nov 1, 2023
8-K Current report
Listing notice, Other events
Sep 22, 2023 Sep 21, 2023
8-K Current report
Regulation FD disclosure
Sep 20, 2023 Sep 20, 2023
DEF 14A Proxy statement Sep 19, 2023 Sep 19, 2023
PRE 14A Preliminary proxy statement Sep 8, 2023 Sep 8, 2023
8-K Current report
Results of operations
Aug 9, 2023 Aug 9, 2023
10-Q Quarterly report Aug 9, 2023 Jun 30, 2023
424B5 Prospectus supplement Jul 7, 2023 —
EFFECT Filing Jun 20, 2023 —
CORRESP Letter to the SEC Jun 16, 2023 —
UPLOAD Letter from the SEC Jun 16, 2023 —
DEL AM Filing Jun 15, 2023 —
S-3 Shelf registration Jun 9, 2023 —
8-K Current report
Results of operations, Regulation FD disclosure, Other events
May 10, 2023 May 10, 2023
10-Q Quarterly report May 10, 2023 Mar 31, 2023
8-K Current report
Regulation FD disclosure, Other events
Apr 18, 2023 Apr 18, 2023
S-8 Employee stock plan registration Mar 31, 2023 —
8-K Current report
Results of operations
Mar 15, 2023 Mar 15, 2023
10-K Annual report Mar 15, 2023 Dec 31, 2022
8-K Current report
Regulation FD disclosure, Other events
Jan 30, 2023 Jan 30, 2023
8-K Current report
Regulation FD disclosure, Other events
Jan 12, 2023 Jan 12, 2023
8-K Current report
Regulation FD disclosure
Dec 29, 2022 Dec 29, 2022
8-K Current report
Shareholder vote results
Nov 14, 2022 Nov 14, 2022
8-K Current report
Results of operations, Regulation FD disclosure
Nov 2, 2022 Nov 2, 2022
10-Q Quarterly report Nov 2, 2022 Sep 30, 2022
8-K Current report
Regulation FD disclosure, Other events
Oct 21, 2022 Oct 21, 2022
DEF 14A Proxy statement Sep 22, 2022 Sep 22, 2022
8-K Current report
Regulation FD disclosure
Sep 13, 2022 Sep 13, 2022
10-Q Quarterly report Aug 11, 2022 Jun 30, 2022
8-K Current report
Results of operations
Aug 11, 2022 Aug 11, 2022
8-K Current report
Results of operations, Regulation FD disclosure
May 12, 2022 May 12, 2022
10-Q Quarterly report May 12, 2022 Mar 31, 2022
8-K Current report
Regulation FD disclosure
Apr 13, 2022 Apr 13, 2022
8-K Current report
Regulation FD disclosure, Other events
Apr 11, 2022 Apr 11, 2022
S-8 Employee stock plan registration Apr 1, 2022 —
10-K/A Amended annual report Mar 11, 2022 Dec 31, 2021
8-K Current report
Results of operations
Mar 8, 2022 Mar 8, 2022
10-K Annual report Mar 8, 2022 Dec 31, 2021
8-K Current report
Regulation FD disclosure, Other events
Jan 25, 2022 Jan 25, 2022
8-K Current report
Regulation FD disclosure, Other events
Dec 16, 2021 Dec 16, 2021
8-K Current report
Officer or director change, Regulation FD disclosure
Dec 6, 2021 Dec 6, 2021
10-Q Quarterly report Nov 8, 2021 Sep 30, 2021
8-K Current report
Results of operations
Nov 8, 2021 Nov 8, 2021
8-K Current report
Shareholder vote results
Nov 1, 2021 Nov 1, 2021
8-K Current report
Officer or director change, Regulation FD disclosure, Other events
Sep 20, 2021 Sep 17, 2021
DEF 14A Proxy statement Sep 17, 2021 Sep 17, 2021
8-K Current report
Regulation FD disclosure, Other events
Sep 13, 2021 Sep 13, 2021
8-K Current report
Results of operations
Aug 10, 2021 Aug 10, 2021
10-Q Quarterly report Aug 10, 2021 Jun 30, 2021
8-K Current report
Results of operations
May 10, 2021 May 10, 2021
10-Q Quarterly report May 10, 2021 Mar 31, 2021
8-K Current report
Results of operations
Mar 29, 2021 Mar 29, 2021
10-K Annual report Mar 29, 2021 Dec 31, 2020
S-8 Employee stock plan registration Feb 26, 2021 —
8-K Current report
Regulation FD disclosure, Other events
Feb 1, 2021 Feb 1, 2021
8-K Current report
Shareholder vote results
Jan 27, 2021 Jan 26, 2021
8-K Current report
Regulation FD disclosure
Jan 14, 2021 Jan 14, 2021
8-K Current report
Other events
Dec 28, 2020 Dec 28, 2020
DEF 14A Proxy statement Dec 17, 2020 Jan 26, 2021
8-K Current report
Regulation FD disclosure, Other events
Dec 8, 2020 Dec 7, 2020
PRE 14A Preliminary proxy statement Dec 7, 2020 Jan 26, 2021
8-K Current report
Officer or director change, Regulation FD disclosure
Dec 1, 2020 Dec 1, 2020
8-K Current report
Material agreement, New debt, Regulation FD disclosure
Nov 25, 2020 Nov 19, 2020
8-K Current report
Results of operations
Nov 6, 2020 Nov 6, 2020
10-Q Quarterly report Nov 6, 2020 Sep 30, 2020
8-K Current report
Shareholder vote results
Nov 4, 2020 Nov 2, 2020
8-K Current report
Regulation FD disclosure, Other events
Oct 19, 2020 Oct 19, 2020
DEF 14A Proxy statement Oct 1, 2020 Oct 1, 2020
8-K Current report
Officer or director change, Other events
Sep 15, 2020 Sep 11, 2020
424B5 Prospectus supplement Aug 10, 2020 —
8-K Current report
Results of operations
Aug 10, 2020 Aug 10, 2020
10-Q Quarterly report Aug 10, 2020 Jun 30, 2020
EFFECT Filing Aug 7, 2020 —
CORRESP Letter to the SEC Jul 31, 2020 —
CORRESP Letter to the SEC Jul 27, 2020 —
S-3/A Filing Jul 27, 2020 —
UPLOAD Letter from the SEC Jul 16, 2020 —
8-K Current report
Material agreement
Jul 2, 2020 Jul 2, 2020
S-3 Shelf registration Jul 2, 2020 —
8-K Current report
Regulation FD disclosure
Jun 2, 2020 Jun 2, 2020
8-K Current report
Results of operations
May 11, 2020 May 11, 2020
10-Q Quarterly report May 11, 2020 Mar 31, 2020
S-8 Employee stock plan registration Mar 20, 2020 —
8-K Current report
Results of operations
Mar 9, 2020 Mar 9, 2020
10-K Annual report Mar 9, 2020 Dec 31, 2019
8-K Current report
Agreement ended
Feb 20, 2020 Feb 19, 2020
424B5 Prospectus supplement Jan 13, 2020 —
8-K Current report
Material agreement, Regulation FD disclosure, Other events
Jan 10, 2020 Jan 9, 2020
424B5 Prospectus supplement Jan 9, 2020 —
10-Q Quarterly report Nov 13, 2019 Sep 30, 2019
8-K Current report
Shareholder vote results
Nov 1, 2019 Nov 1, 2019
DEF 14A Proxy statement Sep 24, 2019 Sep 24, 2019
UPLOAD Letter from the SEC Sep 24, 2019 —
PRER14A Filing Sep 23, 2019 —
CORRESP Letter to the SEC Sep 23, 2019 —
UPLOAD Letter from the SEC Sep 20, 2019 —
PRE 14A Preliminary proxy statement Sep 13, 2019 Sep 13, 2019
8-K Current report
Results of operations, Regulation FD disclosure
Aug 13, 2019 Aug 13, 2019
10-Q Quarterly report Aug 13, 2019 Jun 30, 2019
8-K Current report
Results of operations
May 14, 2019 May 14, 2019
10-Q Quarterly report May 13, 2019 Mar 31, 2019
8-K Current report
Results of operations
Apr 2, 2019 Apr 2, 2019
10-K Annual report Apr 1, 2019 Dec 31, 2018
424B5 Prospectus supplement Mar 18, 2019 —
8-K Current report
Material agreement, Regulation FD disclosure, Other events
Mar 15, 2019 Mar 15, 2019
424B5 Prospectus supplement Mar 14, 2019 —
8-K Current report
Officer or director change, Regulation FD disclosure
Feb 25, 2019 Feb 22, 2019
8-K Current report
Officer or director change, Regulation FD disclosure
Jan 3, 2019 Dec 31, 2018
10-Q Quarterly report Nov 9, 2018 Sep 30, 2018
8-K Current report
Shareholder vote results
Nov 2, 2018 Nov 1, 2018
8-K Current report
Officer or director change, Regulation FD disclosure
Oct 15, 2018 Oct 15, 2018
DEF 14A Proxy statement Sep 24, 2018 Nov 1, 2018
8-K Current report
Officer or director change, Regulation FD disclosure
Sep 6, 2018 Sep 5, 2018
10-Q Quarterly report Aug 9, 2018 Jun 30, 2018
424B5 Prospectus supplement Jun 19, 2018 —
8-K Current report
Material agreement, Unregistered share sale, Change to shareholder rights, Bylaw or fiscal year change, Regulation FD disclosure
Jun 19, 2018 Jun 19, 2018
424B5 Prospectus supplement Jun 19, 2018 —
8-K Current report
Officer or director change
Jun 18, 2018 Jun 14, 2018
10-K/A Amended annual report Jun 14, 2018 Dec 31, 2017

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
MTNB (NYSE)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Bedminster, NJ
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1582554

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.